Difficulty: Medium
Average Score: 94%
Practice
A 52-year-old postmenopausal patient has evidence of low bone mineral density. She and her physician are considering therapy with raloxifene or a combination of conjugated estrogens and medroxyprogesterone acetate. Which of the following patient characteristics is most likely to lead them to select raloxifene?
Correct answer
D
Rationale
Raloxifene is preferred over estrogen therapy in patients with a strong family history of breast cancer due to its lack of estrogenic effects on breast tissue and lower breast cancer risk.